Erythropoietin Use and the Risk of Stroke in Patients on Hemodialysis: A Retrospective Cohort Study in Taiwan

BACKGROUND: Targeting higher hemoglobin levels with erythropoietin to treat anemia in patients with chronic kidney disease is associated with increased cardiovascular risk, including that of stroke. The risks of the subtypes of stroke, ischemic, hemorrhagic, and unspecified, following the administra...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Peir‐Haur, Yeh, Chih‐Ching, Hsiao, Chih‐Yen, Muo, Chih‐Hsin, Hung, Kuan‐Yu, Tsai, Kuen‐Jer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483460/
https://www.ncbi.nlm.nih.gov/pubmed/34176302
http://dx.doi.org/10.1161/JAHA.120.019529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483460/
https://www.ncbi.nlm.nih.gov/pubmed/34176302
http://dx.doi.org/10.1161/JAHA.120.019529

Ejemplares similares